Dipanwita Basu, Ph.D.
About Dipanwita Basu, Ph.D.
Dipanwita Basu, Ph.D., is a Program Officer for Covid-19 Therapeutics and Diagnostics at the National Institutes of Health, where she has worked since 2021. With over 15 years of experience in genetics and molecular research, she has contributed significantly to the field through various roles and numerous publications.
Work at National Institutes of Health
Dipanwita Basu, Ph.D., currently serves as a Program Officer for COVID-19 Therapeutics and Diagnostics at the National Institutes of Health (NIH). She has held this position since 2021 and has been involved in critical initiatives related to COVID-19. Prior to this role, she worked as a Program Coordinator for the COVID-19 Rapid Acceleration of Diagnostics (RADx) program from 2020. Her tenure at NIH also includes a role as Program Manager for the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs from 2019 to 2020.
Education and Expertise
Dipanwita Basu holds a Doctor of Philosophy (PhD) in Plant Molecular Biology/Genetics from Purdue University, where she studied from 2002 to 2006. She also earned a Master's degree in Biochemistry, Biophysics, and Molecular Biology from the University of Calcutta between 1998 and 2000. Her undergraduate education includes a Bachelor of Applied Science in Plant Biology from Presidency College, completed from 1995 to 1998. She has over 15 years of experience in genetics, molecular, biochemical, and microbiological research.
Background
Dipanwita Basu has a diverse professional background that includes significant roles in both academia and government. She worked as a Research Scientist at the University of Virginia from 2006 to 2010. Prior to her current positions at NIH, she served as an SBIR-STTR Program Specialist/Scientist at the National Institute of Allergy and Infectious Diseases (NIAID) from 2018 to 2019. Additionally, she gained research experience as a Research Assistant at Purdue University from 2002 to 2006.
Achievements
Dipanwita Basu has contributed to numerous peer-reviewed journal publications throughout her career, reflecting her extensive research experience. She has served as Principal Investigator on NIH-NIAID SBIR phase I and II grants that focused on drug discovery for influenza viruses. Her work spans over 7 years in the Pharmaceutical, Biotechnology, and Healthcare industries, showcasing her expertise in these fields.